Symbiotec Pharmalab Limited

NSE:SYMBIOTECHealth TechnologyNSE:NIFTY_IPO

——At close · Market cap —

SYMBIOTEC · Balance sheet · TradingHolo

INR billions	FY2022	FY2023	FY2024	YoY
Cash & cash equivalents	0.0	0.1	0.3	+252.1%
Cash & short-term investments	0.1	0.1	0.3	+250.0%
Receivables	1.4	1.4	1.9	+37.1%
Inventory	2.5	3.4	2.7	−22.1%
Total current assets	4.0	5.1	4.9	−3.0%
Property, plant & equipment	5.8	7.1	9.9	+38.9%
Total assets	9.9	12.9	15.8	+22.0%
Payables	0.9	2.3	0.9	−61.1%
Short-term debt	1.1	0.5	2.9	+450.0%
Total current liabilities	2.3	3.5	4.7	+34.6%
Long-term debt	1.1	2.0	2.6	+29.1%
Total debt	2.2	2.5	5.4	+117.3%
Net debt	2.1	2.4	5.2	+113.1%
Total liabilities	3.7	5.8	7.6	+31.9%
Total equity	6.2	7.2	8.1	+14.0%
Retained earnings	4.5	5.5	6.4	+17.5%

INR billionsUpdated 30 Jun 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.